Added to YB: 2026-03-04
Pitch date: 2026-03-02
PRTC [neutral]
PureTech Health plc
-0.96%
current return
Author Info
The Oak Bloke shares analysis of the UK stock market, particularly overlooked small caps. Sign up for the newsletter.
Company Info
PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States.
Market Cap
GBP 399.4M
Pitch Price
GBP 1.25
Price Target
N/A
Dividend
N/A
EV/EBITDA
-1.82
P/E
8.20
EV/Sales
35.17
Sector
Biotechnology
Category
value
PRTC-e for the big day
PRTC (holding update): Biotech hub down 12% YTD while sector +30-50% (BridgeBio +140%, Roivant +35%). LYT-100 just got FDA/EU orphan designation for IPF, Ph3 trial 1H26. Spokes: Seaport ($325M raised, 35% stake), Vedanta (VE303 late-stage), Karuna 2% royalty on Cobenfy sales >$2B (peak $5B+ est). ~£300M mkt cap vs $320M net cash = pipeline/spokes valued at zero despite 80% clinical success rate.
Read full article (3 min)